Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Figge

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Cell|June 5, 1987
lac repressor can regulate expression from a hybrid SV40 early promoter containing a lac operator in animal cellsM Brown, J Figge, U Hansen, et al.
Cell|September 1, 1982
Role of small t antigen in the acute transforming activity of SV40H Rubin, J Figge, M T Bladon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 1, 1996
Increased bcl-2 protein levels in prostatic adenocarcinomas are not associated with rearrangements in the 2.8 kb major breakpoint region or with p53 protein accumulationB V Kallakury, J Figge, B Leibovich, et al.
Protein Science : a Publication of the Protein Society|February 1, 1993
The binding domain structure of retinoblastoma-binding proteinsJ Figge, K Breese, S Vajda, et al.
Clinical Practice in Pediatric Psychology|August 2, 2021
Exploring Predictors of Treatment Engagement in Urban Integrated Primary CareJennifer A Mautone, Beatriz Cabello, Theresa E Egan, et al.
Cell|July 15, 1988
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility geneJ A DeCaprio, J W Ludlow, J Figge, et al.
Cancer|March 15, 1994
Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53R A Ambros, P A Vigna, J Figge, et al.
Experimental and Molecular Pathology|December 1, 1994
Preferential expression of the cell adhesion molecule CD44 in papillary thyroid carcinomaJ Figge, A D del Rosario, G Gerasimov, et al.
Cancer|October 1, 1996
Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidyB V Kallakury, F Yang, J Figge, et al.
Frontiers in Public Health|October 31, 2022
Experiences and Perceptions of Telephone-delivery of the Common Elements Treatment Approach for Mental Health Needs Among Young People in Zambia During the COVID-19 PandemicSaphira Munthali-Mulemba, Caleb J Figge, Kristina Metz, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Cell|June 5, 1987
lac repressor can regulate expression from a hybrid SV40 early promoter containing a lac operator in animal cellsM Brown, J Figge, U Hansen, et al.
Cell|September 1, 1982
Role of small t antigen in the acute transforming activity of SV40H Rubin, J Figge, M T Bladon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 1, 1996
Increased bcl-2 protein levels in prostatic adenocarcinomas are not associated with rearrangements in the 2.8 kb major breakpoint region or with p53 protein accumulationB V Kallakury, J Figge, B Leibovich, et al.
Protein Science : a Publication of the Protein Society|February 1, 1993
The binding domain structure of retinoblastoma-binding proteinsJ Figge, K Breese, S Vajda, et al.
Clinical Practice in Pediatric Psychology|August 2, 2021
Exploring Predictors of Treatment Engagement in Urban Integrated Primary CareJennifer A Mautone, Beatriz Cabello, Theresa E Egan, et al.
Cell|July 15, 1988
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility geneJ A DeCaprio, J W Ludlow, J Figge, et al.
Cancer|March 15, 1994
Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53R A Ambros, P A Vigna, J Figge, et al.
Experimental and Molecular Pathology|December 1, 1994
Preferential expression of the cell adhesion molecule CD44 in papillary thyroid carcinomaJ Figge, A D del Rosario, G Gerasimov, et al.
Cancer|October 1, 1996
Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidyB V Kallakury, F Yang, J Figge, et al.
Frontiers in Public Health|October 31, 2022
Experiences and Perceptions of Telephone-delivery of the Common Elements Treatment Approach for Mental Health Needs Among Young People in Zambia During the COVID-19 PandemicSaphira Munthali-Mulemba, Caleb J Figge, Kristina Metz, et al.
Pageof 9